Efficacy of combined Transcutaneous Electrical Nerve Stimulation with task-oriented training on hand functions in stroke patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202408646333823

Enrollment

Registered

2024-08-22

Start date

2023-04-02

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nervous System Diseases

Interventions

Task Oriented Training program

Combined Transcutaneous Electrical Nerve Stimulation with Task Oriented Training program

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patient's age ranged from 45-65 years. 2. All participants had an ischemic stroke recruited (ischemic/ hemorrhage) with a duration of illness ranged from one to six months prior to enrollment. 3. Mild spasticity of the affected hand muscles ranging from 1 to 1+ according to modified Ashworth scale. 4. All patients were muscles test for wrist and finger extensor , flexor at least grade (3) MMT. 5. muscles power in the wrist and finger flexor/initiation of active extension of the wrist and fingers test results of manual muscle tests of the affected hand Grade ‘fair’. 6. Patients had sufficient cognitive and communication abilities and were able to understand and follow instructions (Mini-Mental Scale >24). 7. Patients had a body mass index that did not exceed 35. 8. Patients were medically stable.

Exclusion criteria

Exclusion criteria: 1.All Participants exclusion criteria in treatment research on neurological disorders (e.g. Parkinson’s disease or Alzheimer’s disease), musculoskeletal problems (e.g. deformities or a recent fracture), sever aphasia. A praxia, sever heart and lung disease, skin conditions or injuries,a malignant tumor and cognitive impairment 2.Upper extrimity sensory deficits attributable to nonstroke pathology, such as diabetes or peripheral neuropathy 3.Intolerance to TENS or participation in another experimental rehabilitation project during the duration of treatment. 4.Treatment with botulinum toxin. 5.Severe uncontrolled hypertension. 6.had participated in other rehabilitation or drug trials.

Design outcomes

Primary

Measure	Time frame
Semmes-Weinstein Monofilament (SWM)test ,Two-point Discrimination (2PD)test and Fugl-Meyer assessment upper extremity- sensory part test.	—

Secondary

Measure	Time frame
Box and Blocks Test of Hand Function , Fugl-Meyer assessment upper extremity (FMA-UE) - motor part test, 9 hole peg test, dynamometer hand- grip strength test , Hydraulic pinch gauge lateral pinch test	—

Countries

Egypt

Contacts

Public ContactAhmed Yasin

Supervisor Head of Occupational Therapy Department Al Aqsa University

shokryys@hotmail.com00972594203026

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026